E2007-G000-238: An Open-Label Study With an Extension Phase to Evaluate the Pharmacokinetics of Perampanel (E2007) Oral Suspension When Given as an Adjunctive Therapy in Subjects From 1 Month to Less Than 24 Months (<2 years) of Age With Epilepsy

Grants and Contracts Details

StatusFinished
Effective start/end date9/29/16 → 9/30/18

Funding

  • Eisai Incorporated: $7,990.00